Raymond James Financial’s PDS Biotechnology PDSB Stock Holding History
Bought
Maintained
Sold
Other funds holding PDSB
Raymond James Financial's PDSB Position: Q3 2026 in Review
Raymond James Financial sold out of PDS Biotechnology (PDSB) in Q3 2026, closing a stake of 33,819 shares — an estimated $29.8K sold.
Raymond James Financial first reported a position in PDSB in Q4 2024 and held it in 7 quarters. The position peaked at $29.8K in Q2 2026. 60 funds tracked by Wall St. Rank hold PDSB as of Q3 2026.
- Raymond James Financial reported no remaining PDS Biotechnology position as of Q3 2026 after selling out during the quarter.
- Raymond James Financial sold 33,819 PDS Biotechnology shares in Q3 2026, an estimated $29.8K.
- Raymond James Financial first reported a position in PDS Biotechnology in Q4 2024 and held it in 7 quarters.
- Raymond James Financial's PDS Biotechnology position peaked at $29.8K in Q2 2026.
- 60 funds tracked by Wall St. Rank held PDS Biotechnology as of Q3 2026.
Based on Raymond James Financial's 13F filing for Q3 2026, filed 12 Nov 2026.